. Author manuscript; available in PMC: 2021 Mar 1.

Published in final edited form as: J Steroid Biochem Mol Biol. 2019 Dec 23;197:105566. doi: 10.1016/j.jsbmb.2019.105566

Table 4:

Differences in plasma levels of oxysterols between patients grouped by clinical data

Oxysterols^a
Clinical characteristics		25HC	27HC	7αHC	7KC	βEC	CT
Age at diagnosis		0.589	0.007	0.002	0.011	0.027	0.032
	Spearman’s correlation coefficient σ	- 0.087	0.348	0.405	0.938	0.301	0.298
	Without outliers^b	-	0.112	0.006	-	0.026	-
	Spearman’s correlation coefficient σ	-	0.225	0.370	-	0.308	-
Menopausal status (pre vs. post)		0.866	0.044	0.068	0.778	0.053	0.143
	Without outliers^b	-	0.181	0.102	-	0.079	-
Histology type (ductal vs. other)		0.822	0.450	0.181	0.578	0.733	0.722
Tumor grade (G1 vs. G2/G3)		0.933	0.321	0.219	0.873	0.199	0.479
Tumor size (pT1 vs. pT2-4)		0.376	0.011	0.007	0.077	0.072	0.089
	Without outliers^b	-	0.017	0.003	-	0.038	-
Lymph node metastasis (pN01 vs. pN1)		0.790	0.202	0.528	0.581	0.108	0.152
Pathological stage (SIA vs.other)		0.580	0.007	0.035	0.392	0.015	0.018
Pathological stage (SIA vs.other)	Without outliers^b	-	0.143	0.182	-	0.022	-
Progesterone receptor (positive vs. negative)		0.531	0.957	0.907	0.526	0.917	0.214

A p-value by the Kruskal-Wallis or p-value and correlation coefficient for the Spearman test presented.

Significant results were reanalyzed also without outliers. Confirmed significant results are underlined.